What Are the Attributes Prioritized in the Choice of Therapy in Chronic Lymphocytic Leukemia? A Patient-physician Cross-matching Analysis of a Discrete Choice Experiment

por Laurenti, Luca, Gaidano, Gianluca, Mauro, Francesca Romana, Molica, Stefano, Pasqualetti, Patrizio, Scarfò, Lydia, Ghia, Paolo
Publicado 2022

A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Def...

por Visentin, Andrea, Molinari, Maria Chiara, Pravato, Stefano, Cellini, Alessandro, Angotzi, Francesco, Cavaretta, Chiara Adele, Ruocco, Valeria, Imbergamo, Silvia, Piazza, Francesco, Proietti, Giulia, Mauro, Francesca Romana, Trentin, Livio
Publicado 2022

Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort

por Reda, Gianluigi, Mattiello, Veronica, Frustaci, Anna Maria, Visentin, Andrea, Mauro, Francesca Romana, Innocenti, Idanna, Gentile, Massimo, Giannarelli, Diana, Noto, Alessandro, Cassin, Ramona, Neri, Antonino, Laurenti, Luca, Tedeschi, Alessandra
Publicado 2022

Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituxim...

por Peragine, Nadia, De Propris, Maria Stefania, Intoppa, Stefania, Milani, Maria Laura, Mariglia, Paola, Mauro, Francesca Romana, Raponi, Sara, Soddu, Stefano, Cuneo, Antonio, Rigolin, Gian Matteo, Del Giudice, Ilaria, Foà, Robin, Guarini, Anna
Publicado 2020

Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy

por Porrazzo, Marika, Nicolai, Emanuele, Riminucci, Mara, Vitale, Candida, Coscia, Marta, De Paoli, Lorenzo, Rago, Angela, Buscicchio, Giulia, Maestrini, Giacomo, Ligia, Silvio, Di Prima, Alessio, Corsi, Alessandro, Caronna, Roberto, Gaidano, Gianluca, Mauro, Francesca Romana
Publicado 2020

TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia

por Puzzolo, Maria Cristina, Del Giudice, Ilaria, Peragine, Nadia, Mariglia, Paola, De Propris, Maria Stefania, Cappelli, Luca Vincenzo, Trentin, Livio, Reda, Gianluigi, Cuneo, Antonio, Molica, Stefano, Piciocchi, Alfonso, Arena, Valentina, Mauro, Francesca Romana, Guarini, Anna, Foà, Robin
Publicado 2021

Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia

por Cafforio, Luciana, Raponi, Sara, Cappelli, Luca Vincenzo, Ilari, Caterina, Soscia, Roberta, De Propris, Maria Stefania, Mariglia, Paola, Rigolin, Gian Matteo, Bardi, Antonella, Peragine, Nadia, Piciocchi, Alfonso, Arena, Valentina, Mauro, Francesca Romana, Cuneo, Antonio, Guarini, Anna, Foà, Robin, Del Giudice, Ilaria
Publicado 2021

Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the L...

por Autore, Francesco, Innocenti, Idanna, Corrente, Francesco, Del Principe, Maria Ilaria, Rosati, Serena, Falcucci, Paolo, Fresa, Alberto, Conte, Esmeralda, Limongiello, Maria Assunta, Renzi, Daniela, De Padua, Laura, Andriani, Alessandro, Pisani, Francesco, Cimino, Giuseppe, Tafuri, Agostino, Montanaro, Marco, Mauro, Francesca Romana, Del Poeta, Giovanni, Laurenti, Luca
Publicado 2020

The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation

por Visentin, Andrea, Bonaldi, Laura, Rigolin, Gian Matteo, Mauro, Francesca Romana, Martines, Annalisa, Frezzato, Federica, Pravato, Stefano, Gargarella, Leila Romano, Bardi, Maria Antonella, Cavallari, Maurizio, Volta, Eleonora, Cavazzini, Francesco, Nanni, Mauro, Facco, Monica, Piazza, Francesco, Guarini, Anna, Foà, Robin, Semenzato, Gianpietro, Cuneo, Antonio, Trentin, Livio
Publicado 2021

The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia

por Visentin, Andrea, Bonaldi, Laura, Rigolin, Gian Matteo, Mauro, Francesca Romana, Martines, Annalisa, Frezzato, Federica, Imbergamo, Silvia, Scomazzon, Edoardo, Pravato, Stefano, Bardi, Maria Antonella, Cavallari, Maurizio, Volta, Eleonora, Cavazzini, Francesco, Nanni, Maurizio, Del Giudice, Ilaria, Facco, Monica, Guarini, Anna, Semenzato, Gianpietro, Foà, Robin, Cuneo, Antonio, Trentin, Livio
Publicado 2019

Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia

por Morabito, Fortunato, Tripepi, Giovanni, Moia, Riccardo, Recchia, Anna Grazia, Boggione, Paola, Mauro, Francesca Romana, Bossio, Sabrina, D’Arrigo, Graziella, Martino, Enrica Antonia, Vigna, Ernesto, Storino, Francesca, Fronza, Gilberto, Di Raimondo, Francesco, Rossi, Davide, Condoluci, Adalgisa, Colombo, Monica, Fais, Franco, Fabris, Sonia, Foa, Robin, Cutrona, Giovanna, Gentile, Massimo, Montserrat, Emili, Gaidano, Gianluca, Ferrarini, Manlio, Neri, Antonino
Publicado 2021

HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia

por Griggio, Valentina, Vitale, Candida, Todaro, Maria, Riganti, Chiara, Kopecka, Joanna, Salvetti, Chiara, Bomben, Riccardo, Bo, Michele Dal, Magliulo, Daniela, Rossi, Davide, Pozzato, Gabriele, Bonello, Lisa, Marchetti, Monia, Omedè, Paola, Kodipad, Ahad Ahmed, Laurenti, Luca, Del Poeta, Giovanni, Mauro, Francesca Romana, Bernardi, Rosa, Zenz, Thorsten, Gattei, Valter, Gaidano, Gianluca, Foà, Robin, Massaia, Massimo, Boccadoro, Mario, Coscia, Marta
Publicado 2020

Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study

por Visentin, Andrea, Mauro, Francesca Romana, Catania, Gioachino, Fresa, Alberto, Vitale, Candida, Sanna, Alessandro, Mattiello, Veronica, Cibien, Francesca, Sportoletti, Paolo, Gentile, Massimo, Rigolin, Gian Matteo, Quaglia, Francesca Maria, Murru, Roberta, Gozzetti, Alessandro, Molica, Stefano, Marchetti, Monia, Pravato, Stefano, Angotzi, Francesco, Cellini, Alessandro, Scarfò, Lydia, Reda, Gianluigi, Coscia, Marta, Laurenti, Luca, Ghia, Paolo, Foà, Robin, Cuneo, Antonio, Trentin, Livio
Publicado 2022

Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12

por Autore, Francesco, Strati, Paolo, Innocenti, Idanna, Corrente, Francesco, Trentin, Livio, Cortelezzi, Agostino, Visco, Carlo, Coscia, Marta, Cuneo, Antonio, Gozzetti, Alessandro, Mauro, Francesca Romana, Frustaci, Anna Maria, Gentile, Massimo, Morabito, Fortunato, Molica, Stefano, Falcucci, Paolo, D’Arena, Giovanni, Murru, Roberta, Vincelli, Donatella, Efremov, Dimitar G, Ferretti, Antonietta, Rigolin, Gian Matteo, Vitale, Candida, Tisi, Maria Chiara, Reda, Gianluigi, Visentin, Andrea, Sica, Simona, Foà, Robin, Ferrajoli, Alessandra, Laurenti, Luca
Publicado 2019

Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

por Mauro, Francesca Romana, Giannarelli, Diana, Visentin, Andrea, Reda, Gianluigi, Sportoletti, Paolo, Frustaci, Anna Maria, Chiarenza, Annalisa, Ciolli, Stefania, Vitale, Candida, Laurenti, Luca, De Paoli, Lorenzo, Murru, Roberta, Gentile, Massimo, Rigolin, Gian Matteo, Levato, Luciano, Giordano, Annamaria, Del Poeta, Giovanni, Stelitano, Caterina, Ielo, Claudia, Noto, Alessandro, Guarente, Valerio, Molica, Stefano, Coscia, Marta, Tedeschi, Alessandra, Gaidano, Gianluca, Cuneo, Antonio, Foà, Robin, Martelli, Maurizio, Girmenia, Corrado, Gentile, Giuseppe, Trentin, Livio
Publicado 2021

Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?

por Tedeschi, Alessandra, Frustaci, Anna Maria, Mauro, Francesca Romana, Chiarenza, Annalisa, Coscia, Marta, Ciolli, Stefania, Reda, Gianluigi, Laurenti, Luca, Varettoni, Marzia, Murru, Roberta, Baratè, Claudia, Sportoletti, Paolo, Greco, Antonino, Borella, Chiara, Rossi, Valentina, Deodato, Marina, Biagi, Annalisa, Zamprogna, Giulia, Pelle, Angelo Curto, Lapietra, Gianfranco, Vitale, Candida, Morelli, Francesca, Cassin, Ramona, Fresa, Alberto, Cavalloni, Chiara, Postorino, Massimiliano, Ielo, Claudia, Cairoli, Roberto, Di Raimondo, Francesco, Montillo, Marco, Del Poeta, Giovanni
Publicado 2021

Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study

por Innocenti, Idanna, Reda, Gianluigi, Visentin, Andrea, Coscia, Marta, Motta, Marina, Murru, Roberta, Moia, Riccardo, Gentile, Massimo, Pennese, Elsa, Quaglia, Francesca Maria, Albano, Francesco, Cassin, Ramona, Deodato, Marina, Ielo, Claudia, Frustaci, Anna Maria, Piciocchi, Alfonso, Rughini, Arianna, Arena, Valentina, Di Sevo, Daniela, Tomasso, Annamaria, Autore, Francesco, Del Poeta, Giovanni, Scarfò, Lydia, Mauro, Francesca Romana, Tedeschi, Alessandra, Trentin, Livio, Pompili, Maurizio, Foà, Robin, Ghia, Paolo, Cuneo, Antonio, Laurenti, Luca
Publicado 2022

Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia

por Frustaci, Anna Maria, Del Poeta, Giovanni, Visentin, Andrea, Sportoletti, Paolo, Fresa, Alberto, Vitale, Candida, Murru, Roberta, Chiarenza, Annalisa, Sanna, Alessandro, Mauro, Francesca Romana, Reda, Gianluigi, Gentile, Massimo, Varettoni, Marzia, Baratè, Claudia, Borella, Chiara, Greco, Antonino, Deodato, Marina, Zamprogna, Giulia, Laureana, Roberta, Cipiciani, Alessandra, Galitzia, Andrea, Curto Pelle, Angelo, Morelli, Francesca, Malvisi, Lucio, Coscia, Marta, Laurenti, Luca, Trentin, Livio, Montillo, Marco, Cairoli, Roberto, Tedeschi, Alessandra
Publicado 2022

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab

por Gentile, Massimo, Martino, Enrica Antonia, Visentin, Andrea, Coscia, Marta, Reda, Gianluigi, Sportoletti, Paolo, Mauro, Francesca Romana, Laurenti, Luca, Varettoni, Marzia, Murru, Roberta, Chiarenza, Annalisa, Vigna, Ernesto, Mendicino, Francesco, Lucia, Eugenio, Bossio, Sabrina, Recchia, Anna Grazia, Moia, Riccardo, Pietrasanta, Daniela, Loseto, Giacomo, Consoli, Ugo, Scortechini, Ilaria, Rossi, Francesca Maria, Zucchetto, Antonella, Al-Janazreh, Hamdi, Vitale, Candida, Tripepi, Giovanni, D’Arrigo, Graziella, Angeletti, Ilaria, Bomben, Riccardo, Neri, Antonino, Cutrona, Giovanna, Fronza, Gilberto, Di Raimondo, Francesco, Gaidano, Gianluca, Cuneo, Antonio, Foà, Robin, Ferrarini, Manlio, Trentin, Livio, Gattei, Valter, Morabito, Fortunato
Publicado 2020

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study

por Cuneo, Antonio, Follows, George, Rigolin, Gian Matteo, Piciocchi, Alfonso, Tedeschi, Alessandra, Trentin, Livio, Perez, Angeles Medina, Coscia, Marta, Laurenti, Luca, Musuraca, Gerardo, Farina, Lucia, Delgado, Alfredo Rivas, Orlandi, Ester Maria, Galieni, Piero, Mauro, Francesca Romana, Visco, Carlo, Amendola, Angela, Billio, Atto, Marasca, Roberto, Chiarenza, Annalisa, Meneghini, Vittorio, Ilariucci, Fiorella, Marchetti, Monia, Molica, Stefano, Re, Francesca, Gaidano, Gianluca, Gonzalez, Marcos, Forconi, Francesco, Ciolli, Stefania, Cortelezzi, Agostino, Montillo, Marco, Smolej, Lukas, Schuh, Anna, Eyre, Toby A., Kennedy, Ben, Bowles, Kris M., Vignetti, Marco, de la Serna, Javier, Moreno, Carol, Foà, Robin, Ghia, Paolo
Publicado 2018